| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |